🔎 Trials Near Me

Home › Dementia › NCT06619327

Resilient Together for Dementia (RT-D)

Recruiting

Resilient Together for Dementia: A Live Video Resiliency Dyadic Intervention for Persons With Dementia and Their Care-partners Early After Diagnosis

Who can join

Ages 18 and older · All sexes

Full eligibility criteria
Inclusion Criteria:

* Recent (\~3 month) chart documented ADRD diagnosis,
* ADRD symptom onset after age 65
* Cognitive assessment scores and symptoms consistent with early stage dementia, as determined by the Clinical Dementia Rating Scale scores of .5 or 1.0
* Cognitive awareness of their problems (as determined by the treating neurologist), and ability to understand study and research protocol, as determined by a standardized teach-back method assessment

Additional inclusion criteria for dyads are:

* English speaking adults (18 years or older)
* Dyad lives together
* At least one partner endorses clinically significant emotional distress during screening (\>7 on Hospital Anxiety and Depression scale subscales or \<5 on the Geriatric Depression Scale)

Exclusion Criteria:

* Patient is deemed inappropriate by the neurology team
* Either partner has a co-occurring terminal illness
* Patient was diagnosed with forms of dementia with clinical profiles that would preclude participation (e.g., Frontotemporal Dementia- behavioral variant), as determined by treatment team.

About the study

This study will evaluate the feasibility and preliminary efficacy of the novel Resilient Together for Dementia (RT-D) intervention for couples following dementia diagnoses. The primary target is emotional distress, and the program aims to prevent chronic distress in at-risk couples.

What is being tested

Sponsor: Icahn School of Medicine at Mount Sinai · Participants: 24 · Started: Feb 19, 2025

Contact the study team

Official record on ClinicalTrials.gov — NCT06619327

Locations in the U.S.

New YorkBrain Injury Research Center at Mount Sinai, New York

Conditions

From ClinicalTrials.gov, data retrieved Oct 2, 2026. Each study sets its own eligibility; the study team decides who can join.